Clinical features and laboratory findings of SARS-CoV-2 infection in hospitalized patients
暂无分享,去创建一个
M. Yue | Xingxiang Liu | Yunfang Xu | Yang Jing | Yan Du | Lijuan Wang | Jing Wu | Yuanyuan Zhang | Jingqi Zhang | Chen Dong
[1] M. Palacios Cruz,et al. COVID-19, una emergencia de salud pública mundial , 2020, Revista Clínica Española.
[2] Huan Cai,et al. Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings , 2020, International Journal of Infectious Diseases.
[3] Qiu Zhao,et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] Char Leung. Clinical features of deaths in the novel coronavirus epidemic in China , 2020, Reviews in medical virology.
[5] Wenjie Yang,et al. Clinical Features and Chest CT Manifestations of Coronavirus Disease 2019 (COVID-19) in a Single-Center Study in Shanghai, China. , 2020, AJR. American journal of roentgenology.
[6] Yuxin Shi,et al. Clinical progression of patients with COVID-19 in Shanghai, China , 2020, Journal of Infection.
[7] Yuyi Wang,et al. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures , 2020, Journal of medical virology.
[8] W. Ko,et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths , 2020, Journal of Microbiology, Immunology and Infection.
[9] D. Murdoch,et al. Clinical course and mortality risk of severe COVID-19 , 2020, The Lancet.
[10] C. Shi,et al. Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multi-centre case series , 2020, medRxiv.
[11] C. Akdis,et al. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China , 2020, Allergy.
[12] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[13] P. Horby,et al. A novel coronavirus outbreak of global health concern , 2020, The Lancet.
[14] Taisheng Li. Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0) , 2020, Emerging microbes & infections.
[15] D. Barreca,et al. Lactate dehydrogenase inhibition: biochemical relevance and therapeutical potential. , 2019, Current medicinal chemistry.
[16] J. Ashworth,et al. Role of C-Reactive Protein at Sites of Inflammation and Infection , 2018, Front. Immunol..
[17] D. McClish,et al. Predictors of MERS-CoV infection: A large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia , 2016, Travel Medicine and Infectious Disease.
[18] Kow-Tong Chen,et al. Hematological and Biochemical Factors Predicting SARS Fatality in Taiwan , 2006, Journal of the Formosan Medical Association.
[19] Y. Leo,et al. Clinical and epidemiological predictors of transmission in Severe Acute Respiratory Syndrome (SARS) , 2006, BMC infectious diseases.
[20] Y. Leo,et al. SARS in Singapore--predictors of disease severity. , 2006, Annals of the Academy of Medicine, Singapore.
[21] R. Perng,et al. Clinical Features and Outcomes of Severe Acute Respiratory Syndrome and Predictive Factors for Acute Respiratory Distress Syndrome , 2005, Journal of the Chinese Medical Association.
[22] Chong-Jen Yu,et al. Clinical Manifestations, Laboratory Findings, and Treatment Outcomes of SARS Patients , 2004, Emerging infectious diseases.
[23] S. Sethi,et al. Severe Acute Respiratory Syndrome without Respiratory Symptoms or Abnormal Chest Radiograph Findings , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.